Bio-Techne TECH
NASDAQ TECH
$72.43 -0.02 (-0.03%)
As of: Sep 4, 2026 · 3:59 PM EDT

Bio-Techne (TECH) Retained Earnings (2009 - 2026)

Bio-Techne (TECH) posted quarterly Retained Earnings of $1.1 billion for Q1 2026, up 1495.69% year-over-year from $71.8 million in Q1 2025, and up 3.47% quarter-over-quarter from $1.1 billion in Q4 2025.

Analysis

Bio-Techne (TECH) Retained Earnings (2009 - 2026) Analysis & Trends

Bio-Techne's Retained Earnings history runs 18 years deep, the most recent figure standing at $1.1 billion for Q1 2026.

  • In Q1 2026, Retained Earnings rose 1495.69% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $1.1 billion (up 1495.69% YoY), while the FY2025 annual figure was $1.1 billion, down 19.56% from the prior year.
  • Retained Earnings for Q1 2026 stood at $1.1 billion, up from $1.1 billion in the prior quarter.
  • The five-year high for Retained Earnings was $1.3 billion in Q3 2023, with the low at -$91.8 million in Q3 2022.
  • The 5-year median for Retained Earnings is $1.1 billion (2025), against an average of $671.2 million.
  • The sharpest annual moves came in 2022 and 2024: Retained Earnings tumbled 106.93% in 2022, then soared 2106.0% in 2024.
  • Bio-Techne's Retained Earnings stood at $1.2 billion in 2022, then grew by 5.12% to $1.3 billion in 2023, then gained by 2.01% to $1.3 billion in 2024, then retreated by 13.98% to $1.1 billion in 2025, then climbed by 3.47% to $1.1 billion in 2026.
  • Business Quant data shows TECH's Retained Earnings at $1.1 billion in Q1 2026, $1.1 billion in Q4 2025, and $1.1 billion in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 15.69 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 37.62 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 558.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.10 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -4.00 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 13.05 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -6.33 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 4.38 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.57 Bn
10 Bio-Techne 11.29 Bn 11.03 Bn 211.39 Mn 1.14 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.14 Bn
Mar 31, 2026 1.15 Bn
Dec 31, 2025 1.11 Bn
Sep 30, 2025 1.08 Bn
Jun 30, 2025 1.07 Bn
Mar 31, 2025 1.20 Bn
Dec 31, 2024 1.29 Bn
Sep 30, 2024 1.34 Bn
Jun 30, 2024 1.33 Bn
Mar 31, 2024 1.30 Bn
Dec 31, 2023 1.26 Bn
Sep 30, 2023 1.33 Bn
Jun 30, 2023 1.31 Bn
Mar 31, 2023 1.25 Bn
Dec 31, 2022 1.20 Bn
Sep 30, 2022 1.16 Bn
Jun 30, 2022 1.12 Bn
Mar 31, 2022 1.13 Bn
Dec 31, 2021 1.15 Bn
Sep 30, 2021 1.12 Bn